来自诱导多能干细胞的工程T细胞:从研究到临床实施
Ratchapong Netsrithong1,2, Laura Garcia-Perez1,2, Maria Themeli1,2
1Department of Hematology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Frontiers in immunology
|January 29, 2024
概括
诱导多能干细胞 (iPSC) 衍生T细胞为采用细胞疗法提供了可扩展的现成解决方案. 本次审查强调了根据良好的制造实践 (GMP) 为临床使用生成这些细胞的进展.
科学领域:
- 细胞免疫疗法细胞免疫疗法
- 再生医学是一种再生医学.
- 基因工程是一种基因工程.
背景情况:
- 传统的T细胞疗法面临着制造限制.
- 诱导多能干细胞 (iPSCs) 为治疗性T细胞提供了可扩展的来源.
- iPSCs允许进行基因修饰以提高安全性和有效性,例如引入嵌合式抗原受体 (CAR).
研究的目的:
- 审查从iPSCs生成功能性工程T细胞的进展.
- 评估iPSC衍生T细胞在临床应用方面的进展.
- 强调在生产中遵守良好制造实践 (GMP) 的重要性.
主要方法:
- 关于iPSC差异化和基因工程协议的最新文献的审查.
- 分析实现低免疫性和特定治疗功能的方法.
- 对临床翻译的可扩展性,安全性和质量控制措施的评估.
主要成果:
- 在过去的十年中,在从iPSC中产生工程T细胞方面取得了重大进展.
- 制定符合GMP标准的协议对于临床实施至关重要.
- 通过iPSC的基因工程,可以创建标准化,严格评估的细胞系.
结论:
- 来自iPSC的T细胞代表了采用细胞疗法的有希望,标准化和可扩展的来源.
- 这种方法为更安全,更广泛应用的工程T细胞产品提供了潜力.
- 专注于iPSCs预示着T细胞治疗的新时代,扩大了更多患者的治疗希望.
相关概念视频
Induced Pluripotent Stem Cells
23.0K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
23.0K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K


